Ana Rodriguez (San Juan / PR), Lester Rosario (San Juan / PR), Yadira Cantres (San Juan / PR), Kelvin Carrasquillo (San Juan / PR), Alexandra Rosa (San Juan / PR), Veronica Rivera (San Juan / PR), Eduardo Tosado-Rodríguez (San Juan / PR), Loyda Méndez (Carolina / PR), Abiel Roche-Lima (San Juan / PR), Jorge Bertran (San Juan / PR), Loyda Meléndez (San Juan / PR)
Viral strains, age, and host factors are associated with variable immune responses against SARS-CoV-2 and disease severity. Puerto Ricans have a genetic mixture of races: European, African, and Native American. We hypothesized that unique host proteins/pathways are associated with COVID-19 disease severity in Puerto Rico and that vaccination reverts these proteins' dysregulation. Following IRB approval, 95 unvaccinated men and women aged 21-71 years-old were recruited in Puerto Rico from 2020-2021. Plasma samples were collected from COVID-19-positive subjects (n = 39) and COVID-19-negative individuals (n = 56) during acute disease. COVID-19-positive individuals were stratified based on symptomatology as follows: mild (n = 18), moderate (n = 13), and severe (n = 8). An additional subgroup of vaccinated participants before COVID-19 infection (n=11) was compared to vaccinated COVID-19-negative individuals (n=15). Quantitative proteomics was performed using Tandem Mass Tag (TMT) labeling in plasma samples. Labeled peptides were subjected to LC/MS/MS and analyzed by Proteome Discoverer, Limma software, and Ingenuity Pathways Analysis (IPA). Cytokines were also quantified using a human cytokine array. Proteomics analyses of severely affected COVID-19-positive individuals revealed 2 upregulated and 54 downregulated proteins. In vaccinated individuals we did not find downregulated proteins. Cytokine immunoassay showed that IL-1Ra, IP-10, and TNF-⍺ levels increased while PDGF decreased with COVID-19 in unvaccinated individuals while only IP-10 was upregulated in vaccinated individuals. This study demonstrates that proteomics studies help uncover potential host predictors of COVID-19 severity in Puerto Ricans modulated by vaccination.
Supported in part by UPR COVID-19 Emergency Funds, National Institutes of Health National Institute of General Medical Sciences (NIGMS), PR-INBRE-Institutional Developmental Award (IDEA) P20GM103475, Research Infrastructure Core components – National Institute of Minority Health and Health Disparities (NIMHHD) U54MD007600, Translational Proteomics Center, and Bioinformatics and Health Informatics, "D-SPAN"- F99NS11345 and K00NS11345.
Auf unserem Internetauftritt verwenden wir Cookies. Bei Cookies handelt es sich um kleine (Text-)Dateien, die auf Ihrem Endgerät (z.B. Smartphone, Notebook, Tablet, PC) angelegt und gespeichert werden. Einige dieser Cookies sind technisch notwendig um die Webseite zu betreiben, andere Cookies dienen dazu die Funktionalität der Webseite zu erweitern oder zu Marketingzwecken. Abgesehen von den technisch notwendigen Cookies, steht es Ihnen frei Cookies beim Besuch unserer Webseite zuzulassen oder nicht.